Prophylactic self-assembled nucleic acid hydrogel targeting retinal ganglion cell cuproptosis and microglial neuroinflammation for retinal ischemia-reperfusion injury.

Retinal ischemia-reperfusion (RIR) injury constitutes a common pathological pathway in glaucoma, diabetic retinopathy, and other neurodegenerative diseases, frequently leading to irreversible neuronal loss. This study identifies concurrent FDX1-dependent retinal ganglion cell (RGC) cuproptosis and MyD88-mediated microglial inflammation as key drivers of retinal neurodegeneration in RIR. To address this, we developed SAH-CIM, a self-assembled nucleic acid hydrogel for sustained co-delivery of siFdx1 and siMyd88. SAH-CIM effectively suppressed RGC cuproptosis via FDX1 knockdown and reduced pro-inflammatory cytokines by inhibiting the MyD88/TRAF6/NF-κB pathway. In murine RIR models, prophylactic SAH-CIM administration preserved 25.3% more retinal ganglion cells than free siRNA controls, with structural integrity confirmed by histological analysis and optical coherence tomography. Functional recovery was evidenced by electroretinography and visual cliff tests, with SAH-CIM treated mice showing 36.6% reduced time on the cliff side. Crucially, the dual-targeting design demonstrated significantly superior therapeutic efficacy over single-target approaches. The highly biocompatible and self-assembled SAH-CIM presents a promising prophylactic resolution for RIR-related diseases with broad translational potential.

• Publication year

  2026

• Venue

  Bioactive Materials

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.bioactmat.2026.01.044PMID 41727276PMCID PMC12918180
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• High-purity AAV vector production utilizing recombination-dependent minicircle formation and genetic coupling

  2025cited by this paper
• Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases

  2025cited by this paper
• In Vivo Interactions of Nucleic Acid Nanostructures With Cells

  2024cited by this paper
• Addressing neurodegeneration in glaucoma: Mechanisms, challenges, and treatments.

  2024cited by this paper
• Immunological Landscape of Retinal Ischemia-Reperfusion Injury: Insights into Resident and Peripheral Immune Cell Responses

  2024cited by this paper
• A Nucleic Acid‐Based LYTAC Plus Platform to Simultaneously Mediate Disease‐Driven Protein Downregulation

  2024cited by this paper
• Free heme induces neuroinflammation and cognitive impairment by microglial activation via the TLR4/MyD88/NF-κB signaling pathway

  2024cited by this paper
• Dexmedetomidine enables copper homeostasis in cerebral ischemia/reperfusion via ferredoxin 1

  2023cited by this paper
• Copper, Lysyl Oxidase Activity, and Collagen in Aqueous Humour of Primary Glaucoma: An Association with Clinical Parameters

  2023cited by this paper
• Safety and Efficacy of Dexamethasone Intravitreal Implant Given Either First-Line or Second-Line in Diabetic Macular Edema

  2023cited by this paper
• In Situ Vaccination with An Injectable Nucleic Acid Hydrogel for Synergistic Cancer Immunotherapy.

  2023cited by this paper
• Single intravitreal administration of a tetravalent siRNA exhibits robust and efficient gene silencing in mouse and pig photoreceptors

  2023cited by this paper
• Retinal Microenvironment‐Protected Rhein‐GFFYE Nanofibers Attenuate Retinal Ischemia‐Reperfusion Injury via Inhibiting Oxidative Stress and Regulating Microglial/Macrophage M1/M2 Polarization

  2023cited by this paper
• Lipid nanoparticles for siRNA delivery in cancer treatment.

  2023cited by this paper
• Copper homeostasis and cuproptosis in cardiovascular disease therapeutics.

  2023cited by this paper
• Inhibiting multiple forms of cell death optimizes ganglion cells survival after retinal ischemia reperfusion injury

  2022cited by this paper
• Spotlight on Targeted Chemotherapy in Retinoblastoma: Safety, Efficacy, and Patient Outcomes

  2022cited by this paper
• TJ-M2010-5, a novel CNS drug candidate, attenuates acute cerebral ischemia-reperfusion injury through the MyD88/NF-κB and ERK pathway

  2022cited by this paper
• Copper induces cell death by targeting lipoylated TCA cycle proteins

  2022cited by this paper
• Neuroprotective Effect of siRNA Entrapped in Hyaluronic Acid-Coated Lipoplexes by Intravitreal Administration

  2021cited by this paper
• PTP70-2, a novel polysaccharide from Polygala tenuifolia, prevents neuroinflammation and protects neurons by suppressing the TLR4-mediated MyD88/NF-κB signaling pathway.

  2021cited by this paper
• Two-Plasmid Packaging System for Recombinant Adeno-Associated Virus

  2020cited by this paper
• Faculty Opinions recommendation of Microglia-organized scar-free spinal cord repair in neonatal mice.

  2020cited by this paper
• Injectable Drug-Conjugated DNA Hydrogel for Local Chemotherapy to Prevent Tumor Recurrence.

  2020cited by this paper
• NLRP12 collaborates with NLRP3 and NLRC4 to promote pyroptosis inducing ganglion cell death of acute glaucoma

  2020cited by this paper
• Progress toward Understanding the Interactions between DNA Nanostructures and the Cell.

  2019cited by this paper
• Culture Systems of Dissociated Mouse and Human Pluripotent Stem Cell-Derived Retinal Ganglion Cells Purified by Two-Step Immunopanning.

  2018cited by this paper
• A Crosslinked Nucleic Acid Nanogel for Effective siRNA Delivery and Antitumor Therapy.

  2018cited by this paper
• Inhibition of MyD88 Signaling Skews Microglia/Macrophage Polarization and Attenuates Neuronal Apoptosis in the Hippocampus After Status Epilepticus in Mice

  2018cited by this paper
• Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma

  2018cited by this paper
• Detection and measurement of clinically meaningful visual field progression in clinical trials for glaucoma

  2017cited by this paper
• Microglia emerge as central players in brain disease

  2017cited by this paper
• HISAT: a fast spliced aligner with low memory requirements

  2015cited by this paper
• Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer.

  2015cited by this paper
• Evolving synergistic combinations of targeted immunotherapies to combat cancer

  2015cited by this paper
• Non-viral vectors for gene-based therapy

  2014cited by this paper
• Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis.

  2014cited by this paper
• Retinal ischemia/reperfusion injury is mediated by Toll-like receptor 4 activation of NLRP3 inflammasomes.

  2014cited by this paper
• The molecular basis of retinal ganglion cell death in glaucoma.

  2012cited by this paper
• CellSpace: A module for creating spatially registered laser ablation images within the Iolite freeware environment

  2012cited by this paper
• Critical pathogenic events underlying progression of neurodegeneration in glaucoma.

  2012cited by this paper
• Iolite: Freeware for the visualisation and processing of mass spectrometric data

  2011cited by this paper
• Aqueous humour and serum zinc and copper concentrations of patients with glaucoma and cataract.

  1990cited by this paper

• No citing papers are available for this paper.